ArticleVaccine2025
Behaviors, perceptions, and impact of the COVID-19 pandemic and vaccination on oncology patients in New Mexico with substantial representation of racial minorities and rural residents.
Article in Vaccine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Postacute Sequelae Following Omicron COVID-19 in Patients With Cancer.JAMA network open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionThe COVID-19 pandemic has affected all sectors of life. This study helps us better understand the perceptions and practices related to the COVID-19 pandemic in the oncology patient population of New Mexico. It also explores patient knowledge regarding safe practices and perceptions regarding vaccination.
methodsThe data for this cross-sectional survey study was collected from July 20, 2021 to September 6, 2021.
resultsThere were no significant differences noted in the incidence of COVID-19 infection based on race, comorbidities, or modality of treatment regardless of vaccination status. During the first peak of COVID-19 (Nov 2020 - Jan 2021), most participants followed strict safety precautions (54.2 %), fewer maintained these practices in the months prior to data collection (32.5 %) (Jul 2021 - Aug 2021). Among the participants who had declined vaccination against COVID-19, there were no significant differences based on race, comorbidities or treatment. Those oncology patients receiving treatments at the infusion center were much less vaccine hesitant (8.3 %) compared to those who were not (18.3 %). The odds of COVID-19 infection among patients that were vaccinated was 0.27 times lower than that of unvaccinated patients (95 % CI, 0.12 to 0.63; p 0.001). Vaccine-hesitant respondents reported long-term safety data (n = 11, 24.4 %) and physician recommendations (n = 10, 22.2 %) were likely to change their minds, but the most common response was that "nothing" would change their mind (n = 16, 35.6 %).
conclusionThe pandemic is a dynamic landscape and physicians need to keep up to date with current guidelines and continue to have conversations with patients regarding strict safety precautions. Having an open discussion with patients regarding vaccine recommendations may help with decreasing vaccine hesitancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.